603858 Shandong Buchang Pharmaceuticals
- 15.47
- -0.02-0.13%
About Shandong Buchang Pharmaceuticals Company
The company was founded in 2001 and completed the shareholding system reform in 2012. It passed the IPO review by the Securities Regulatory Commission in July 2016 and was successfully listed on November 18, 2016. The company is mainly engaged in R&D, production and sales of proprietary Chinese medicines, and is also entering and expanding in the fields of chemicals, biopharmaceuticals, and vaccines. The company's main products are Brainxintong capsules, Xinxin tablets, Danhong injection, Red Nuclear Medicine, Kang Gynecitis, Prostate Relaxation capsules, Lung Detoxification Granules, Compound Cerebropeptide Injection, Compound Triotide Injection, Gu Hong Injection, Ginkgo Honey Ring Oral Solution, Biopharmaceuticals, and Vaccines. Corporate honors include the “Chinese Manufacturing Champion Enterprise” award, “2017 China Pharmaceutical's Most Socially Responsible Enterprise”, “2017 China Pharmaceutical's Most Growing Product Brand”, and “2017 China Pharmaceutical Investment Association's Top Ten Strategic Cooperation Enterprises”.
Company Profile
Company Executives
- Name
- Position
- Salary
- tao zhao
- Chairman, Directors, Nomination Committee Members, Chairman of the Strategy and Investment Committee
- --
- yimin wang
- Vice Chairman, Directors, Executive Vice President, Member of the Remuneration and Assessment Committee, Member of the Strategy and Investment Committee
- 2.16M
- jing zhao
- Vice Chairman, Directors, Assistant to the Chairman, Member of the Strategy and Investment Committee, Audit Committee Member
- 1.45M
- xin wang
- Directors, Member of the Strategy and Investment Committee
- --
- renhui xue
- Directors, VP
- 2.12M
- chao zhao
- Directors, President, Member of the Strategy and Investment Committee
- 2.44M
- hongwu li
- Independent Directors, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee
- --
- hao wang
- Independent Directors, Audit Committee Member
- --
- hua cheng
- Independent Directors, Chairman of the Audit Committee, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
- 190.50K
- xiaoping pu
- Board Secretary, VP
- 1.40M
- bing wu
- Securities Affairs Representative, Minister of Securities, Employee Supervisors
- 314.50K
- minggeng wang
- Chairman of the Supervisory Board, Director of Production, Employee Supervisors
- 1.14M
- yalin lei
- Auditors
- --
- baocai wang
- Chief Financial Officer
- 1.13M
- xifang wang
- Chief Engineer
- 1.11M
- buzhang zhao
- Lifetime Honorary Chairman
- --
- puxing xu
- Employee Supervisors
- 65.30K
Analysis
Price Target
No Data
